Clearmind Medicine Inc.

NASDAQ (USD): Clearmind Medicine Inc. (CMND)

Last Price

1.22

Today's Change

-0.07 (5.42%)

Day's Change

1.19 - 1.31

Trading Volume

197,515

Overview

Market Cap

3 Million

Shares Outstanding

3 Million

Avg Volume

1,277,458

Avg Price (50 Days)

1.24

Avg Price (200 Days)

4.05

PE Ratio

-0.18

EPS

-6.89

Earnings Announcement

30-Apr-2023

Previous Close

1.29

Open

1.28

Day's Range

1.19 - 1.31

Year Range

0.921 - 20.4

Trading Volume

197,718

Price Change Highlight

1 Day Change

-5.43%

5 Day Change

-8.96%

1 Month Change

2.52%

3 Month Change

-20.78%

6 Month Change

-68.72%

Ytd Change

-56.12%

1 Year Change

-93.41%

3 Year Change

74.91%

5 Year Change

74.91%

10 Year Change

74.91%

Max Change

74.91%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment